Search

Abstract Background Evidence-based practice, decision aids, patient preferences and autonomy preferences (AP) play an important role in making decisions with the patient. They are crucial in the process of a shared decision making (SDM) and can be incorporated into quality criteria for patient involvement in health care. However, there are few studies on SDM and AP in the field of dentistry. This study explored patients’ autonomy preferences in dentistry in comparison to other medical domains, comparing them with patient preferences in two other cohorts of patients with different conditions and in different health care settings. Methods A sample of 100 dental patients attending 16 dentists was consecutively recruited in a university-based prosthodontic clinic. Patients’ and dentists’ preferences regarding their roles in dental decision making for commonly performed diagnostic and treatment decisions were compared using the Control Preference Scale (CPS). This was followed by cross sectional surveys to study autonomy preferences in three additional cohorts recruited from general practices (n = 100), a multiple sclerosis clinic (n = 109), and a university-based prosthodontic clinic (n = 100). A questionnaire with combined items from the Autonomy Preference Index (API) to assess general and the CPS to assess specific preferences was used in the additional cohorts. Results Dentists were less willing to give patients control than patients were willing to enact autonomy. However, decisions about management of tooth loss were considered relevant for a shared decision making by both parties. When comparing cohorts from different samples, the highest AP was expressed by people with multiple sclerosis and the lowest by patients in dentistry (means: dentistry 2.5, multiple sclerosis 2.1, general practice 2.4, p = .035). There were considerable intra-individual differences in autonomy preferences referring to different decision types (p

As an alternative to conventional encapsulation concepts for a double glass photovoltaic (PV) module, we introduce an innovative ionomer-based multi-layer encapsulant, by which the application of additional edge sealing to prevent moisture penetration is not required. The spontaneous moisture absorption and desorption of this encapsulant and its raw materials, poly (ethylene-co-acrylic acid) and an ionomer, are analyzed under different climatic conditions in this work. The relative air humidity is thermodynamically the driving force for these inverse processes and determines the corresponding equilibrium moisture content (EMC). Higher air humidity results in a larger EMC. The homogenization of the absorbed water molecules is a diffusion-controlled process, in which temperature plays a dominant role. Nevertheless, the diffusion coefficient at a higher temperature is still relatively low. Hence, under normal climatic conditions for the application of PV modules, we believe that the investigated ionomer-based encapsulant can “breathe” the humidity: During the day, when there is higher relative humidity, it “inhales” (absorbs) moisture and restrains it within the outer edge of the module; then at night, when there is a lower relative humidity, it “exhales” (desorbs) the moisture. In this way, the encapsulant protects the cell from moisture ingress.

Copyright of Zeitschrift für Bibliothekswesen und Bibliographie is the property of Vittorio Klostermann and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

A novel Three-Point Bending Beam Test (3-PBT) using a Dynamic Shear Rheometer (DSR) with linear drive motor is introduced for testing asphalt binder at low temperature conditions. This 3-PBT in DSR can be used as surrogate for Bending Beam Rheometer (BBR) tests. Advantages in comparison to BBR are that (i) 3-PBT works without harmful cooling medium ethanol, (ii) the amount of asphalt binder for testing is significantly lower (using material equivalent of 10% of BBR tests), (iii) a silicone rubber mold is used for specimen preparation instead of standard aluminum mold for BBR tests, which makes handling easier, and (iv) the loading protocol is more practical without applying contact load manually. The novel 3-PBT in DSR is presented with respect to preparation, installation, and conditioning of specimens, as well as to the loading protocol. Tests were conducted at temperatures of −10, −16, and −20°C. For the purpose of comparison to BBR tests, and of identifying most suitable testing conditions from alternative setups, a test series was run including 9 different asphalt binders. As to BBR tests, two different cooling media were used, i.e., ethanol and air. Finally, all test results obtained from DSR and BBR tests were analyzed in view of precision and correlation. DSR results correlated well with BBR results, while precision of 3-PBT in DSR was found to be satisfying.

Abstract Background There is a steadily increasing quantity of silver nanoparticles (AgNP) produced for numerous industrial, medicinal and private purposes, leading to an increased risk of inhalation exposure for both professionals and consumers. Particle inhalation can result in inflammatory and allergic responses, and there are concerns about other negative health effects from either acute or chronic low-dose exposure. Results To study the fate of inhaled AgNP, healthy adult rats were exposed to 1½-hour intra-tracheal inhalations of pristine 105Ag-radiolabeled, 20 nm AgNP aerosols (with mean doses across all rats of each exposure group of deposited NP-mass and NP-number being 13.5 ± 3.6 μg, 7.9 ± 3.2•1011, respectively). At five time-points (0.75 h, 4 h, 24 h, 7d, 28d) post-exposure (p.e.), a complete balance of the [105Ag]AgNP fate and its degradation products were quantified in organs, tissues, carcass, lavage and body fluids, including excretions. Rapid dissolution of [105Ag]Ag-ions from the [105Ag]AgNP surface was apparent together with both fast particulate airway clearance and long-term particulate clearance from the alveolar region to the larynx. The results are compatible with evidence from the literature that the released [105Ag]Ag-ions precipitate rapidly to low-solubility [105Ag]Ag-salts in the ion-rich epithelial lining lung fluid (ELF) and blood. Based on the existing literature, the degradation products rapidly translocate across the air-blood-barrier (ABB) into the blood and are eliminated via the liver and gall-bladder into the small intestine for fecal excretion. The pathway of [105Ag]Ag-salt precipitates was compatible with auxiliary biokinetics studies at 24 h and 7 days after either intravenous injection or intratracheal or oral instillation of [110mAg]AgNO3 solutions in sentinel groups of rats. However, dissolution of [105Ag]Ag-ions appeared not to be complete after a few hours or days but continued over two weeks p.e. This was due to the additional formation of salt layers on the [105Ag]AgNP surface that mediate and prolonge the dissolution process. The concurrent clearance of persistent cores of [105Ag]AgNP and [105Ag]Ag-salt precipitates results in the elimination of a fraction > 0.8 (per ILD) after one week, each particulate Ag-species accounting for about half of this. After 28 days p.e. the cleared fraction rises marginally to 0.94 while 2/3 of the remaining [105Ag]AgNP are retained in the lungs and 1/3 in secondary organs and tissues with an unknown partition of the Ag species involved. However, making use of our previous biokinetics studies of poorly soluble [195Au]AuNP of the same size and under identical experimental and exposure conditions (Kreyling et al., ACS Nano 2018), the kinetics of the ABB-translocation of [105Ag]Ag-salt precipitates was estimated to reach a fractional maximum of 0.12 at day 3 p.e. and became undetectable 16 days p.e. Hence, persistent cores of [105Ag]AgNP were cleared throughout the study period. Urinary [105Ag]Ag excretion is minimal, finally accumulating to 0.016. Conclusion The biokinetics of inhaled [105Ag]AgNP is relatively complex since the dissolving [105Ag]Ag-ions (a) form salt layers on the [105Ag]AgNP surface which retard dissolution and (b) the [105Ag]Ag-ions released from the [105Ag]AgNP surface form poorly-soluble precipitates of [105Ag]Ag-salts in ELF. Therefore, hardly any [105Ag]Ag-ion clearance occurs from the lungs but instead [105Ag]AgNP and nano-sized precipitated [105Ag]Ag-salt are cleared via the larynx into GIT and, in addition, via blood, liver, gall bladder into GIT with one common excretional pathway via feces out of the body.